| 000 | 01524 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513151223.0 | ||
| 264 | 0 | _c19981116 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0192-6233 | ||
| 024 | 7 |
_a10.1177/019262339802600409 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeaver, J L | |
| 245 | 0 | 0 |
_aAn evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype. _h[electronic resource] |
| 260 |
_bToxicologic pathology _c |
||
| 300 |
_a532-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarcinogenicity Tests _xmethods |
| 650 | 0 | 4 |
_aCarcinogens _xadministration & dosage |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMice, Transgenic _xgenetics |
| 650 | 0 | 4 |
_aPapilloma _xchemically induced |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aSkin Neoplasms _xchemically induced |
| 650 | 0 | 4 |
_aWeight Gain _xdrug effects |
| 700 | 1 | _aContrera, J F | |
| 700 | 1 | _aRosenzweig, B A | |
| 700 | 1 | _aThompson, K L | |
| 700 | 1 | _aFaustino, P J | |
| 700 | 1 | _aStrong, J M | |
| 700 | 1 | _aEllison, C D | |
| 700 | 1 | _aAnderson, L W | |
| 700 | 1 | _aPrasanna, H R | |
| 700 | 1 | _aLong-Bradley, P E | |
| 700 | 1 | _aLin, K K | |
| 700 | 1 | _aZhang, J | |
| 700 | 1 | _aSistare, F D | |
| 773 | 0 |
_tToxicologic pathology _gvol. 26 _gno. 4 _gp. 532-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/019262339802600409 _zAvailable from publisher's website |
| 999 |
_c9681017 _d9681017 |
||